Orexigen Therapeutics Inc. (OREX)

0.14
0.01 7.35
OTC : Health Technology
Prev Close 0.16
Open 0.14
Day Low/High 0.14 / 0.16
52 Wk Low/High 0.09 / 3.13
Volume 22.50K
Avg Volume 1.12M
Exchange OTC
Shares Outstanding 18.89M
EPS -1.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

These 5 Stocks Under $10 Are Set to Soar Higher

These 5 Stocks Under $10 Are Set to Soar Higher

Here's a technical look at how to trade several under-$10 stocks that are poised for breakouts.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under -$10 stocks are poised to breakout and trade higher from current levels.

Orexigen Therapeutics (OREX) Stock Plunges on Q4 Miss

Orexigen Therapeutics (OREX) Stock Plunges on Q4 Miss

Orexigen Therapeutics (OREX) stock is falling on Friday morning after the company posted its 2015 fourth quarter results before today’s market open.

Interesting OREX Put And Call Options For October 21st

Interesting OREX Put And Call Options For October 21st

Investors in Orexigen Therapeutics, Inc. saw new options become available this week, for the October 21st expiration.

8 Stocks Under $10 Making Big Moves Higher

8 Stocks Under $10 Making Big Moves Higher

These stocks trading for less than $10 a share are within range of triggering big breakouts.

Orexigen Therapeutics Stock Sees Short Interest Decline 34%

Orexigen Therapeutics Stock Sees Short Interest Decline 34%

The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 13,255,786 share decrease in total short interest for Orexigen Therapeutics, Inc. , to 25,834,405, a decrease of 33.91% since 12/15/2015.

Orexigen Therapeutics (OREX) Is Today's Strong On High Volume Stock

Orexigen Therapeutics (OREX) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a strong on high relative volume candidate

Orexigen Therapeutics (OREX) Is Weak On High Volume Today

Orexigen Therapeutics (OREX) Is Weak On High Volume Today

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a weak on high relative volume candidate

Weak On High Volume: Orexigen Therapeutics (OREX)

Weak On High Volume: Orexigen Therapeutics (OREX)

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a weak on high relative volume candidate

First Week of OREX July 2016 Options Trading

First Week of OREX July 2016 Options Trading

Investors in Orexigen Therapeutics, Inc. saw new options begin trading this week, for the July 2016 expiration.

Orexigen Therapeutics (OREX) Weak On High Volume Today

Orexigen Therapeutics (OREX) Weak On High Volume Today

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a weak on high relative volume candidate

Strong On High Relative Volume: Orexigen Therapeutics (OREX)

Strong On High Relative Volume: Orexigen Therapeutics (OREX)

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a strong on high relative volume candidate

First Week of December 18th Options Trading For Orexigen Therapeutics (OREX)

First Week of December 18th Options Trading For Orexigen Therapeutics (OREX)

Investors in Orexigen Therapeutics, Inc. saw new options begin trading this week, for the December 18th expiration.

Orexigen Therapeutics (OREX) Is Today's Perilous Reversal Stock

Orexigen Therapeutics (OREX) Is Today's Perilous Reversal Stock

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a "perilous reversal" (up big yesterday but down big today) candidate

Orexigen Therapeutics (OREX) Flagged As Strong On High Volume

Orexigen Therapeutics (OREX) Flagged As Strong On High Volume

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a strong on high relative volume candidate

Orexigen Therapeutics (OREX) Is Today's Strong On High Volume Stock

Orexigen Therapeutics (OREX) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a strong on high relative volume candidate

10 Worst NASDAQ Biotech Stocks in the Third Quarter

10 Worst NASDAQ Biotech Stocks in the Third Quarter

The third quarter was brutal for biotech stocks. Here are the companies that fared the worst.

Weak On High Volume: Orexigen Therapeutics (OREX)

Weak On High Volume: Orexigen Therapeutics (OREX)

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a weak on high relative volume candidate

Orexigen Therapeutics (OREX) Stock Climbs on $60 Million Investment

Orexigen Therapeutics (OREX) Stock Climbs on $60 Million Investment

Orexigen Therapeutics (OREX) shares are rising after the company sold $60 million worth of common stock to Baupost Group.

Orexigen Therapeutics (OREX) Stock: Weak On High Volume Today

Orexigen Therapeutics (OREX) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a weak on high relative volume candidate

Orexigen Therapeutics (OREX) Weak On High Volume Today

Orexigen Therapeutics (OREX) Weak On High Volume Today

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a weak on high relative volume candidate

Strong On High Volume: Orexigen Therapeutics (OREX)

Strong On High Volume: Orexigen Therapeutics (OREX)

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a strong on high relative volume candidate

Commit To Buy Orexigen Therapeutics At $3.50, Earn 22.9% Using Options

Commit To Buy Orexigen Therapeutics At $3.50, Earn 22.9% Using Options

Investors eyeing a purchase of Orexigen Therapeutics, Inc. shares, but tentative about paying the going market price of $4.80/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Orexigen Therapeutics (OREX) Is Weak On High Volume Today

Orexigen Therapeutics (OREX) Is Weak On High Volume Today

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a weak on high relative volume candidate

Orexigen Therapeutics Becomes Oversold (OREX)

Orexigen Therapeutics Becomes Oversold (OREX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Stocks Under $10 Set to Soar Higher

5 Stocks Under $10 Set to Soar Higher

These under-$10 stocks are within range of triggering big breakout trades.

Orexigen Therapeutics (OREX) Highlighted As Weak On High Volume

Orexigen Therapeutics (OREX) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Orexigen Therapeutics (OREX) as a weak on high relative volume candidate

Orexigen Therapeutics (OREX) Stock Continues to Sink on Contrave Study Fallout

Orexigen Therapeutics (OREX) Stock Continues to Sink on Contrave Study Fallout

Orexigen Therapeutics (OREX) shares are falling nearly double digits after its Contrave development partner threatened to end their relationship over its plans to halt an ongoing Light study.

TheStreet Quant Rating: D- (Sell)